160 related articles for article (PubMed ID: 21494779)
1. Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.
Argiana V; Eleftheriadou I; Tentolouris N
Curr Diab Rep; 2011 Aug; 11(4):294-301. PubMed ID: 21494779
[TBL] [Abstract][Full Text] [Related]
2. Sudomotor dysfunction is associated with foot ulceration in diabetes.
Tentolouris N; Marinou K; Kokotis P; Karanti A; Diakoumopoulou E; Katsilambros N
Diabet Med; 2009 Mar; 26(3):302-5. PubMed ID: 19317826
[TBL] [Abstract][Full Text] [Related]
3. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet.
Sun PC; Lin HD; Jao SH; Chan RC; Kao MJ; Cheng CK
Diabet Med; 2008 Apr; 25(4):413-8. PubMed ID: 18341593
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
[TBL] [Abstract][Full Text] [Related]
5. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol.
Fernando ME; Crowther RG; Cunningham M; Lazzarini PA; Sangla KS; Golledge J
BMC Endocr Disord; 2015 Oct; 15():59. PubMed ID: 26499881
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of diabetic foot ulceration.
Murray HJ; Boulton AJ
Clin Podiatr Med Surg; 1995 Jan; 12(1):1-17. PubMed ID: 7720025
[TBL] [Abstract][Full Text] [Related]
7. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
8. Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study.
Panagoulias GS; Eleftheriadou I; Papanas N; Manes C; Kamenov Z; Tesic D; Bousboulas S; Tentolouris A; Jude EB; Tentolouris N
Front Endocrinol (Lausanne); 2020; 11():625. PubMed ID: 33013702
[No Abstract] [Full Text] [Related]
9. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
Richard JL; Reilhes L; Buvry S; Goletto M; Faillie JL
Int Wound J; 2014 Apr; 11(2):147-51. PubMed ID: 22892021
[TBL] [Abstract][Full Text] [Related]
10. Autonomic and sensory nerve function in diabetic foot ulceration.
McFadden JP; Corrall RJ; O'Brien IA
Clin Exp Dermatol; 1991 May; 16(3):193-6. PubMed ID: 1934571
[TBL] [Abstract][Full Text] [Related]
11. Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration.
Aso Y; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Diabet Med; 2002 Jan; 19(1):19-26. PubMed ID: 11869299
[TBL] [Abstract][Full Text] [Related]
12. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?
McNeely MJ; Boyko EJ; Ahroni JH; Stensel VL; Reiber GE; Smith DG; Pecoraro RF
Diabetes Care; 1995 Feb; 18(2):216-9. PubMed ID: 7729300
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of recurrence in patients with diabetes mellitus and diabetic polineuropathy: A randomized clinical trial.
López-Moral M; Lázaro-Martínez JL; García-Morales E; García-Álvarez Y; Álvaro-Afonso FJ; Molines-Barroso RJ
PLoS One; 2019; 14(7):e0219537. PubMed ID: 31295292
[TBL] [Abstract][Full Text] [Related]
14. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function.
Tsigos C; White A; Young RJ
Diabet Med; 1992 May; 9(4):359-65. PubMed ID: 1600708
[TBL] [Abstract][Full Text] [Related]
15. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes.
Khaodhiar L; Dinh T; Schomacker KT; Panasyuk SV; Freeman JE; Lew R; Vo T; Panasyuk AA; Lima C; Giurini JM; Lyons TE; Veves A
Diabetes Care; 2007 Apr; 30(4):903-10. PubMed ID: 17303790
[TBL] [Abstract][Full Text] [Related]
16. Variability in activity may precede diabetic foot ulceration: response to Armstrong et al.
Lemaster J; Mueller MJ; Sinacore DR
Diabetes Care; 2004 Dec; 27(12):3028; author reply 3028-9. PubMed ID: 15562245
[No Abstract] [Full Text] [Related]
17. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
18. Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction.
Sun PC; Chen CS; Kuo CD; Lin HD; Chan RC; Kao MJ; Wei SH
Microvasc Res; 2012 Mar; 83(2):243-8. PubMed ID: 21722653
[TBL] [Abstract][Full Text] [Related]
19. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?
Carrington AL; Shaw JE; Van Schie CH; Abbott CA; Vileikyte L; Boulton AJ
Diabetes Care; 2002 Nov; 25(11):2010-5. PubMed ID: 12401748
[TBL] [Abstract][Full Text] [Related]
20. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot.
Abouaesha F; van Schie CH; Griffths GD; Young RJ; Boulton AJ
Diabetes Care; 2001 Jul; 24(7):1270-4. PubMed ID: 11423514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
